February 2018

Limbrel recalled, linked to serious side effects

Limbrel, a medical food marketed for osteoarthritis, has been recalled by Primus Pharmaceuticals. The recall was prompted by about 200 reports of adverse events, including several cases of liver toxicity and lung problems. All unexpired lots of Limbrel have been recalled per FDA request. Healthcare providers should tell any patients taking this product to stop using it immediately. Any patients who experienced lung or liver symptoms while taking Limbrel should report them to their provider.

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.